SAH-EZH2 TP2115
Specifications
| 1mg/5mg/10mg/25mg/50mg/100mg |
Bioactivity:
EZH2/EPP interaction inhibitor (Kd = 320 nM). Suppresses EZH2 expression and H3K27 trimethylation by PCR2 complex. Arrests proliferation and induces monocyte to macrophage differentiation of MLL-AF9 leukemia cell line.
CAS nr:
1453222-26-8
Purity:
98%
Molecular Weight:
3432,05
SMILES:
Formula:
C155H256N48O40
Pathway:
Target:
